PDCD1 and cardiac arrhythmia: For example, a meta-analysis demonstrated that PD-1 inhibitors combined with CTLA-4 inhibitors significantly increased the risk of grade 5 arrhythmias compared with monotherapy with PD-1 inhibitors alone (42).